July 25, 2014 – Anna Mehler Paperny, Global News
Health Canada wants ideas on how to stop risky prescribing of the drugs fuelling Canada’s fastest-growing addictions.
Health Canada looking for ways to make opioid prescribing safer
opioids
Hooked on oxy: How pilfered Canadian pills are fuelling a U.S. health crisis
July 14, 2014 – Anna Mehler Paperny, Global News
Nineteen thousand, two hundred and thirty-seven tablets.
That’s how many pills an Ontario pharmacy employee was able to steal before being caught in February – by far the biggest oxycodone theft reported from a Canadian hospital or pharmacy since January 2012, according to numbers Health Canada gave Global News.
Ontario has no plans to crack down on skyrocketing painkillers
July 14, 2014 – Anna Mehler Paperny, Global News
Canada’s next painkiller crackdown won’t come from Ontario.
Its removal of OxyNEO from the Ontario Drug Benefit successfully sidelined Purdue’s replacement for what was once the most notoriously addictive opioid – OxyContin.
And the province now collects data on all prescriptions filled, not just those the government pays for.
But tackling Canada’s fastest-growing addiction is turning into a game of whack-a-mole: Prescriptions for just about every other potent painkiller are up – way up – in the past two years.
Health Minister considers requiring some drugs be ‘tamper-resistant’
June 16, 2014 – Anna Mehler Paperny, Global News
Federal Health Minister Rona Ambrose is considering requiring certain prescription drugs be tamper-resistant – and she wants to know what you think.
‘This is about keeping people’s feet to the fire’: Report tackles prescription drug abuse
Rebecca Lindell and Anna Mehler Paperny, Global News
This isn’t the first slew of suggestions on how to tackle Canada’s “crisis” in prescription opioid misuse. But many hope it’ll be the last.
A report released Wednesday by the Canadian Centre for Substance Abuse culminates a year-long mind-meld of people representing almost every group in the country with a stake in stopping painkillers from creating addicts, drug dealers and deaths.
Who pops the most painkillers? How Canada’s opioid use compares with the rest of the world
Click to compare Canada’s hydromorph contin consumption with the rest of the world.
Used to be that America could easily claim the title of world opioid capital. But when it comes to the most powerful prescription drugs, Canada is now ahead – in part because of higher hydromorphone use.
OxyContin’s gone, but Canada’s pill-popping problem is worse than ever
Photo by Michelle Siu for the Globe and Mail
Anna Mehler Paperny, Global News
A year after provincial governments clamped down on the most notorious name in prescription-drug abuse, other, more powerful, less regulated opioids are filling the void – with sometimes fatal results.
OxyContin’s off the market, its tamper-resistant replacement tougher to get. But Canadians are popping more pills than ever: In 2010, for the first time, Canada edged past the United States to become the highest opioid-consuming country, per capita, in the world.
And more Canadians are dying from it: In 2011, twice as many Ontarians were killed by opioid overdoses as drivers killed in car accidents, according to coroner’s statistics given to Global News. That toll has more than tripled since 2002.
One company, two drugs, two takes on pill safety
Anna Mehler Paperny, Global News
Purdue Pharmaceuticals markets a long-acting, non-tamper resistant opioid in Canada but argues that another long-acting, non-tamper resistant opioid in the U.S. is too dangerous to approve.
In an 80-page submission to the U.S. Food and Drug Administration last July – quoting Ontario Health Minister Deb Matthews, among several others – Purdue argued that allowing generic versions of OxyContin on the market without tamper-proofing mechanisms “would have a number of detrimental effects and would be flatly inconsistent with the Agency’s mission to promote and protect the public health.”
Ontario urges feds not to allow generic OxyContin onto market
Michelle Siu for the Globe and Mail
Saturday, July 7, 2012 – Globe and Mail
ANNA MEHLER PAPERNY
Ontario is “strongly urging” the federal government not to let generic brands of the popular painkiller OxyContin into Canada once Purdue Pharmaceuticals’ patent runs out this fall.
The expiration of Purdue’s OxyContin patent on Nov. 25 opens the door for other companies to manufacture cheaper generic versions of the controlled-release oxycodone. Purdue will continue to make a new, tamper-resistant patented drug – OxyNEO – introduced to replace OxyContin earlier this year.
Ontario doctors still in the dark on drug database
Remember back when Ontario rolled out an online narcotics-prescription database – one meant to track exactly who is prescribing what to whom? The idea is to prevent “double-doctoring” and ensuring that doctors, pharmacists and Health Ministry officials ensure that people who need drugs are getting them.
The database was in testing phase as of November, 2011 and was supposed to be operational early this year. But the people prescribing the drugs still can’t access it. That means they have no idea what other drugs a potential patient could be taking, or was taking. In some cases, it means patients can’t get the drugs they need.
Toronto doctor Irfan Dhalla said doctors still have no idea when they’re going to get in on this database – but they’d really, really like to.
a business of misfits 